Sponsored Webcast: Planning for a Successful Initial IND and Moving Beyond: Regulatory CMC Considerations for Biotherapeutics and Cell and Gene Therapies (On-Demand)

On-demandOn-demand Member: $0 | NonMember: $25 Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)GlobalNorth America